Added to YB: 2026-09-15
Pitch date: 2026-09-11
SNN [bullish]
Smith & Nephew plc
-0.04%
current return
Author Info
No bio for this author
Company Info
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally.
Market Cap
GBP 11.5B
Pitch Price
GBP 28.41
Price Target
N/A
Dividend
2.87%
EV/EBITDA
9.36
P/E
18.54
EV/Sales
2.30
Sector
Health Care Equipment and Supplies
Category
value
Theodosian Capital | Stocks Update 11/9/2026 - SN/ – Terming out, but at a cost
SNN (update): Smith & Nephew remains inexpensive at 10.5x 2028 earnings with a 3.4% yield, supporting continued share repurchases. Its new $700m of 2036 notes at 5.75% extend maturities, with up to $250m retiring cheaper 2030 notes and the balance likely prefunding $490m due in H1 2027. The trade-off is higher interest expense; a rerating could justify modest deleveraging toward an A rating.
Read full article (1 min)